Interregional Innovation Investments Strand 1 (I3-2026-INV1): EU Scale-Up Support for Cross-Regional Innovation
EISMEA’s I3-2026-INV1 call supports cross-border innovation investments through EU consortia with financial and advisory support, with a total 2026 budget of EUR 28.2 million and a single-stage deadline of 12 November 2026.
Interregional Innovation Investments Strand 1 (I3-2026-INV1): EU Scale-Up Support for Cross-Regional Innovation
The Interregional Innovation Investments Strand 1 call, reference I3-2026-INV1, is an EU funding opportunity led by EISMEA for partnerships that can deliver market-ready innovation through interregional collaboration. It is officially listed as open, with the call page publication date on 13 May 2026 and a single-stage deadline on 12 November 2026 at 17:00 CET.
This is a strong fit for organisations that already have an implementation trajectory and want to accelerate deployment, market uptake, and replication across regions with complementary smart specialisation priorities.
The official page confirms that I3-2026-INV1 is for innovation investments that strengthen EU value chains by combining financial support with advisory support in commercialization, intellectual property, standardisation, demonstration, and piloting.
Key details table
| Field | Details |
|---|---|
| Funding body | European Innovation Council and SMEs Executive Agency (EISMEA) |
| Call reference | I3-2026-INV1 |
| Type | Interregional Innovation Investments Strand 1 (I3 Instrument) |
| Status | Open |
| Publication date | 13 May 2026 |
| Opening date | 13 May 2026 |
| Deadline model | Single-stage |
| Deadline | 12 November 2026, 17:00 CET |
| Total estimated call budget | EUR 28.2 million |
| Maximum grant per project | EUR 10 million |
| EU contribution level | 70% EU contribution for all beneficiaries and cost categories |
| FSTP support | up to EUR 100,000 (Financial Support to Third Parties) |
| Eligibility scope | Consortia in EU Member States and EEA contracting parties |
| Readiness requirement | I3 business cases should start from a minimum TRL 6 and focus on demonstration and commercialization |
| Official URL | https://eismea.ec.europa.eu/funding-opportunities/calls-proposals/interregional-innovation-investments-strand-1-i3-2026-inv1_en |
What this call is designed to fund
I3 Strand 1 is not a grant for early conceptual science alone. It is explicitly positioned as a near-market scaling instrument for regional innovation investments. The call language states that projects should help build and expand interregional value chains, strengthen collaboration between regions with different development levels, and support innovation actors with investment ideas that are ready to become mature business cases.
This is why it is often treated as a bridge between early R&D pathways and commercial deployment. If your project is mostly basic research, it is likely too early. If your project has demonstrable technical validation and a credible commercialization path, it can be a good fit.
The call includes both financial support and non-financial support. Financial support can be delivered directly to consortium beneficiaries or through financial support to third parties. Advisory support can include commercialization support, business and investment planning, IP strategy, certification, standardisation, and support for testing and piloting.
In practice, this means reviewers will expect two layers of quality:
- technical and innovation quality of the solution, and
- practical readiness to deploy, scale, and attract follow-on investment.
Projects that are only “promising but vague” tend to fail on this call because the mechanism is expected to generate market-relevant outcomes.
Who this opportunity supports
The page frames this as a programme for innovation actors from the “quadruple helix” ecosystem: industry, academia, public organisations, and wider innovation stakeholders. In practical terms, this includes SMEs and regional innovation intermediaries that can share implementation burden and execution responsibility.
Because call language repeatedly emphasises SMEs and regional value chains, an SME-led or SME-centric consortium tends to align better, but SMEs are not the only type of partner. The right mix is usually:
- at least one company positioned for scale, commercialization, or production uptake,
- one or more research or technical organisations with implementation capability,
- regional innovation or public actors who understand policy and territorial priorities,
- and advisory or support partners able to handle legal, IP, and partnership complexity.
Your consortium should not be built as a token list of names. Each partner should own a specific deliverable. This matters because evaluation committees and administrators increasingly check whether the project can actually run, not just whether the narrative is ambitious.
Eligibility logic in practical terms
The I3 programme page gives strong clues on structural expectations that should guide your eligibility check:
- Consortia are central, with participation across regions.
- Projects are expected to be close to market.
- The call has explicit budget and support thresholds.
- Minimum TRL condition applies at project start, with emphasis on demonstration and scaling.
For this 2026 call, you should treat the eligibility phase as a pre-submission checkpoint in your project plan. If your consortium is incomplete or your technology readiness is lower than the required level, you should pause and close those gaps before preparing the full narrative.
To avoid wasted cycles:
- Fix partner count and legal roles first.
- Confirm that each partner can deliver a specific part of implementation.
- Confirm financing assumptions against the EUR 10 million per project envelope.
- Confirm whether your business case can be described as investable and scalable inside the I3 framework.
It is also important to understand that I3 Strand 1 is part of a wider EU structure. That usually means call text and additional annex instructions on the Funding & Tenders Portal can refine interpretation details that are not repeated on the short call page. You should always verify partner-type requirements and final forms there.
Financial structure and budget expectations
The budget numbers are unusually useful for planning:
- total estimated call budget: EUR 28.2 million,
- up to EUR 10 million per project,
- up to EUR 100,000 in FSTP,
- 70% EU contribution for all beneficiaries and cost categories.
Compared with many EU innovation lines that can feel abstract, this call gives a useful financial envelope so teams can set a realistic budget architecture early.
An effective budget approach should include these principles:
- Prioritise budget lines that directly support demonstration, deployment, and market readiness.
- Keep advisory and validation costs explicit and tightly linked to concrete milestones.
- Show balanced spend between direct technical actions and commercialization support.
- If using FSTP, ensure it directly enables downstream implementation for a named third-party partner.
The call has no broad requirement here for a single “minimum” project amount on the page we have. That means teams should still avoid overfitting budgets to guesswork. The safer route is a modular budget table with a clear narrative showing why each spending block is necessary to move from TRL to replication.
How to read this call as an applicant
This call is best treated as a market-readiness checkpoint, not only a research checkpoint.
A useful way to evaluate fit is by asking five questions:
- Is the opportunity addressing a real value chain problem already rooted in multiple regions?
- Is there at least one lead company that can absorb and apply the investment quickly?
- Are partnership links commercially credible, not ceremonial?
- Are outputs tied to deployment and uptake in a real market context?
- Can the consortium explain how this intervention improves cohesion and competitiveness together?
If you can answer all five clearly, you are likely in the right lane.
This call is also suitable for projects that already have technical proof and need an innovation investment engine for scale. If your idea is still pre-commercial and needs foundational research, this might be too early. If your idea already has validation data but no regional coalition and no implementation roadmap, you might still fail.
Preparation strategy before drafting
A disciplined pre-application sequence reduces rejection risk:
1) Build the coalition before writing the proposal
Given that this is a consortium-centric call, your first deliverable should be a signed or near-signed consortium agreement. The application itself should be written to reflect existing project governance, not to compensate for missing structure.
2) Assign a lead and map each partner’s role
Define one lead entity for reporting and external communication. Map partner deliverables to milestones. In EU calls, reviewers read governance and execution as heavily as technical novelty.
3) Define the commercialization path first
Describe three outcomes:
- measurable pilot or demonstration result,
- clear path for replication,
- and realistic next-stage investment/follow-on logic.
4) Anchor readiness in measurable TRL milestones
Use the TRL 6 starting point as a floor. If parts of your consortium are below that level, explain which package components are above and why integration still remains coherent.
5) Keep the cross-border logic explicit
Because this is interregional, the proposal should show value chain logic across regions, not just list participants. Define what region gains and what each region contributes.
6) Prepare annex-level evidence
Gather:
- regional support letters where possible,
- technical proof-of-concept evidence,
- clear budgets and co-financing logic,
- commercialization or customer validation indicators,
- timeline showing the path to uptake, replication, and growth.
Application path and timeline
As posted, I3-2026-INV1 is open from 13 May 2026 with a single-stage deadline on 12 November 2026. In practice this means two phases:
- early concept and partner build,
- and single submission package build.
Because it is a single-stage call, there is no second major revision window after submission. This increases pressure on proposal completeness.
When planning your internal timeline, use at least three internal deadlines:
- internal draft freeze one week before formal close,
- technical review at T-minus 10 days,
- legal/partner role signoff at least five days before upload.
If a key partner delays, the whole proposal may lose credibility on implementation risk. Build contingency by identifying backup roles early.
Common mistakes in this type of call
- Treating this as a generic research grant. The mechanism expects market-ready investment logic, not only technical novelty.
- Weak interregional rationale. If you cannot explain how regions connect and scale together, the consortium claim weakens.
- Undefined project manager and partner governance. Reviewers interpret this as execution risk.
- Budget structure not tied to market milestones. Too many teams allocate budget top-down without matching technical and commercialization phases.
- No clear commercial trajectory. It is insufficient to show a prototype; you need a route to deployment and replication.
- Assuming small one-party funding is enough. The call expects a multi-actor investment framework; partner coordination is central.
- Underestimating portal requirements. Even when call pages are concise, submission instructions in linked official systems can include additional mandatory details.
Review checklist for your draft
Use this quick pass before submission:
- Does the proposal explain why the project belongs to an interregional value chain?
- Are at least several eligible actors from different regions represented with clear roles?
- Are targets and milestones measurable within the grant period?
- Is the TRL starting point and progression to deployment credible?
- Does the budget directly support the implementation pathway?
- Are advisory/support actions explicitly connected to commercialization and uptake?
- Are all partner details clean, complete, and internally consistent?
Frequently asked questions
Is this only for companies in one country?
No. The mechanism is explicitly interregional and focuses on collaborations across EU/EEA contexts. The consortium design and project outputs should reflect collaboration across regions.
Is there support only as funding and no advisory support?
No. The opportunity emphasizes a combination of financial support and non-financial support including commercialization support, certification, standardisation, and support for piloting.
Can universities and public entities apply?
Yes, when they participate in the right ecosystem partnership with implementable market outcomes. The call text is written around the innovation ecosystem, not a single institution model.
Is this a one-time open opportunity?
The specific reference I3-2026-INV1 is a published call with a single-stage deadline date in 2026. That means application timing is fixed to that window.
Is the budget too broad?
The call provides an overall budget and project-level ceiling. What matters for competitiveness is proof of a realistic, credible implementation and commercialization design.
Practical next steps for teams ready to apply
- Confirm eligibility and partner map against the official page and portal guidance.
- Freeze project scope around a measurable commercial endpoint.
- Draft a partner matrix with responsibility, budget, and milestones.
- Build a short investor-style summary for each output.
- Prepare the full narrative and cross-check against official submission fields.
- Prepare for the portal upload process ahead of the single deadline.
Final perspective
I3-2026-INV1 is best interpreted as a competitive regional growth instrument. It is strongest for teams that already have technical substance and are now seeking the kind of coordinated investment support that connects technical outputs to market traction across regions.
If your project can show that the same solution can be rolled beyond one local context, that your partners bring complementary execution strengths, and that the investment unlocks demonstrable commercialization, this call is likely a strong match.
For official reference and current status, use the direct call page:
The portal route for application-specific forms and additional requirements should be checked in the Funding and Tenders environment before final submission.
